What could possibly connect broccoli, a Slovak professor and more than half a century of scientific research?
Sulforaphane. A natural substance that is talked about all over the world today and that holds the interest of chemists, molecular biologists and experimental oncologists alike. Its story, though, is a great deal older than it might seem. And it has a very interesting Czechoslovak thread running through it. One of the notable figures of the early research into isothiocyanates was the Slovak scientist Prof. RNDr. Katarína Horáková, DrSc.
Her work takes us right back to the laboratories of the 1960s.
What is sulforaphane?
Sulforaphane is one of the isothiocyanates — organic compounds whose molecules carry a characteristic group made up of sulphur, carbon and nitrogen. That is what gives them their typical sharp, faintly bitter taste and penetrating smell. Anyone who has ever grated horseradish, sliced a radish or opened a jar of wasabi knows it very well: isothiocyanates are the thing that stings the nose.
Sulforaphane is associated above all with the brassicas — broccoli, cauliflower, kale and Brussels sprouts. Young broccoli sprouts are another interesting plant source.
How sulforaphane forms in the plant
In an undamaged plant there is virtually no sulforaphane to be found. The plant holds its precursor, called glucoraphanin — and, kept well apart from it, the enzyme that is able to break that precursor down.
When the plant tissue is disrupted, by slicing, crushing or chewing for instance, the two components meet and the enzyme myrosinase enters the process. Under the right conditions, chemical reactions then follow that lead to the formation of sulforaphane. For the plant this is a form of defence that is set off only at the moment of damage; its interest for chemists comes only second.
Myrosinase is a protein, and like other proteins it is damaged by higher temperatures. The sulforaphane content therefore differs between raw vegetables and vegetables that have been boiled for a long time. This is no secret — it is ordinary kitchen chemistry, which scientists in the laboratory nevertheless have to watch quite as carefully as the composition of a culture medium. And sulforaphane, along with other substances from the isothiocyanate group, has been drawing the attention of scientists for several decades now.
A scientist, not a physician
One thing is worth saying at the outset. Katarína Horáková was not a practising doctor and did not work with patients. She was a researcher — a natural scientist who watched in the laboratory how cell cultures behave in the presence of precisely defined chemical substances. She assessed no product, and the text below is not her opinion on anything that can be bought. It is the history of laboratory research into one group of compounds.
What is more, she worked on the boundary between two fields that were only then learning to work together: chemical synthesis and cell biology. Together with her colleagues she studied the biological action of natural and synthetic isothiocyanates alike — substances, that is, which you will not find in any plant at all, because they came into being in the laboratory as variations on a natural template. She did so at a time when today's methods of molecular biology were not available in the slightest.
One part of her scientific work is especially interesting. Research into isothiocyanates also reached into the field of experimental oncology.
1968: isothiocyanates and tumour cells
In 1968 Katarína Horáková published, together with other Czechoslovak scientists, a paper in the specialist journal Neoplasma under the title:
“Cytotoxic and cancerostatic activity of isothiocyanates and related compounds. I. Activity of some naturally occurring isothiocyanates and their synthetic analogues on HeLa-cells.”
The subject of the study was the laboratory examination of naturally occurring isothiocyanates and their synthetic analogues on HeLa cells.
HeLa cells are one of the best-known human cell lines in the history of biomedical research. They are cells that can divide practically without limit under laboratory conditions and could therefore be grown and sent between laboratories the world over — unlike tissue taken for a single experiment. That is precisely what made them the standard material on which, in the sixties, the response of a cell to newly prepared compounds was put to the test.
And it was not the only study. In the same year the team published a further paper on the action of a different group of isothiocyanates on HeLa cells. Horáková, with František Kalafut, also published work following the morphological changes in HeLa cells under cytotoxic concentrations of isothiocyanates — that is, how a cell changes its shape and structure under the microscope. This was therefore not a one-off experiment but broader research into this group of substances, spanning several years.
What does research on tumour cells actually mean?
Here a very important distinction has to be drawn. If scientists find a particular effect of a substance on tumour cells under laboratory conditions, that does not mean that the substance in question acts against a tumour disease in a human being, or that it is able to ward one off. Research on cell cultures is one of the basic tools of experimental science. It makes it possible, for example, to follow how cells respond to a given substance and which cellular or molecular mechanisms may be involved in that response.
A cell in a plastic dish, though, is in an entirely different situation from a cell in a living organism. The substance reaches it at a concentration the experimenter has chosen, it need not undergo any transformation and it need not travel any distance. Only further research can show what significance such observations carry in a living organism — and with many substances it turns out to be none.
The research goes on, more than half a century later
More than 50 years have passed since Katarína Horáková's first papers.
What science can do has changed dramatically in that time. Laboratories today can follow individual signalling pathways, gene expression, enzymatic processes and other mechanisms about which scientists half a century ago had only limited information. That is why sulforaphane is still the subject of experimental research today. The specialist literature examines its interactions with various cellular and molecular mechanisms, for example cell signalling pathways, the regulation of gene expression, the cell cycle and programmed cell death.
One area of scientific interest is also the Nrf2 signalling pathway. Sulforaphane likewise turns up in present-day experimental oncology research, where scientists study its behaviour and its action at the molecular and cellular level.
The results of experimental research, however, must not be mistaken for a proven preventive or remedial effect in human beings.
A story ahead of its time
This is exactly where the story of Professor Katarína Horáková becomes so fascinating. Picture Czechoslovakia in 1968. No genetic sequencing as we know it. No modern databases holding millions of specialist publications. None of the technology that today lets scientists follow what goes on inside a cell almost at the molecular level. Results were written into laboratory notebooks, observations were made at the microscope, and the specialist literature arrived late, if it arrived at all. And yet, in Czechoslovak laboratories, isothiocyanates and their action on human tumour cells were being investigated.
More than half a century on, the scientific world is still occupied with this group of substances.
Sulforaphane is no “new miracle”
Perhaps that is the most interesting thing of all about its story. Sulforaphane is not a substance that appeared out of nowhere alongside a modern nutrition trend. Behind the research into isothiocyanates lie decades of scientific work — and decades of questions that have stayed open.
From simple cell cultures to the molecular biology of today, scientists have been trying to understand in ever finer detail how these substances interact with living cells. And part of the history of that research is the Slovak professor Katarína Horáková.
Her work is a reminder of one important feature of real science: some questions can be interesting enough that scientists come back to them even after more than half a century. And of another thing as well — that between a laboratory finding and an answer to the question “what does this mean for a human being” the road tends to be whole generations of researchers long.
Would you like to look at the original scientific papers?
- Horáková K., Drobnica L., Nemec P., Antos A., Kristián P. (1968)
Cytotoxic and cancerostatic activity of isothiocyanates and related compounds. I. Activity of some naturally occurring isothiocyanates and their synthetic analogues on HeLa-cells.
Neoplasma 15(2): 169–176. PMID: 5658012 - Horáková K., Drobnica L., Nemec P., Kristián P., Antos K. (1968)
Cytotoxic and cancerostatic activity of isothiocyanates and related compounds. II. Activity of substituted phenylisothiocyanates on HeLa-cells.
Neoplasma 15(2): 177–182. PMID: 5658013 - Horáková K., Kalafut F. (1968)
Morfologické zmeny HeLa buniek, vyvolané cytotoxickými koncentráciami izotiokyanátov.
Biologia (Bratislava) 23(6): 438–445. PMID: 4875734
A note
This article is informative and educational in character and describes the history and the fields of scientific research. It does not assess or describe any particular product and does not relate to anything in our range. The laboratory studies mentioned are not evidence that sulforaphane, or foods or food supplements containing it, prevent, diagnose or remedy tumour or other diseases. Sulforaphane is not presented in this article as a medicinal product.